| Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment (NCT02745600) | University of Leipzig | 2016-02-01 |
| Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver (NCT02110953) | Fox Chase Cancer Center | 2016-01-29 |
| Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases (NCT02511522) | Canadian Cancer Trials Group | 2015-12-11 |
| Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor (NCT02465112) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2015-09-01 |
| CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases (NCT02416466) | Roger Williams Medical Center | 2015-04-01 |
| Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer (NCT02355353) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-02-01 |
| Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer (NCT02226276) | City of Hope Medical Center | 2015-01-07 |
| The Role of Tumor-associated Macrophages in Colorectal Liver Metastases (NCT03888638) | Humanitas Clinical and Research Center | 2015-01-01 |
| Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma (NCT02107755) | Ohio State University Comprehensive Cancer Center | 2014-09-05 |
| Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases (NCT02162563) | Dutch Colorectal Cancer Group | 2014-07-01 |
| Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung (NCT01741597) | City of Hope Medical Center | 2014-07-01 |
| ALPPS Versus PVE/PL (NCT02215577) | Regionalt Cancercentrum Väst | 2014-06-01 |
| Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases (NCT02185443) | University of Sao Paulo | 2014-05-01 |
| Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery (NCT02031536) | ECOG-ACRIN Cancer Research Group | 2014-04-10 |
| Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT (NCT02119065) | University of Cincinnati | 2014-01-30 |
| AvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Cancer (NCT02053324) | Alfasigma S.p.A. | 2013-11-11 |
| Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II (NCT02352259) | Institute of Oncology Ljubljana | 2013-09-01 |
| Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases (NCT01861873) | University of Aarhus | 2013-08-01 |
| Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases (NCT01508000) | European Organisation for Research and Treatment of Cancer - EORTC | 2013-06-01 |
| The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum (NCT02079389) | Odense University Hospital | 2013-05-01 |
| A Study of Pancreatic Cancer in Xenografts From Liver Metastases (NCT01774643) | University Health Network, Toronto | 2013-01-01 |
| Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project (NCT01815879) | Andrew Kennedy | 2012-12-01 |
| Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases (NCT01646554) | European Organisation for Research and Treatment of Cancer - EORTC | 2012-12-01 |
| Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases (NCT01730157) | Case Comprehensive Cancer Center | 2012-12-01 |
| CCR5-blockade in Metastatic Colorectal Cancer (NCT01736813) | National Center for Tumor Diseases, Heidelberg | 2012-11-01 |
| Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases (NCT01631318) | Stanford University | 2012-11-01 |
| Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer (NCT01763450) | Liaoning Cancer Hospital & Institute | 2012-09-01 |
| Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC (NCT01631539) | Universitaire Ziekenhuizen KU Leuven | 2012-09-01 |
| Proton Therapy in the Treatment of Liver Metastases (NCT01697371) | Loma Linda University | 2012-08-22 |
| Detection of CTCs in Patients Undergoing Surgery for Stage IV Colorectal Cancer (NCT01722903) | Milton S. Hershey Medical Center | 2012-08-01 |
| Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions (NCT01862900) | Providence Health & Services | 2012-04-27 |
| Stereotactic Body Radiation Therapy (SBRT) for Liver Mets (NCT01360606) | Susannah Ellsworth | 2012-03-23 |
| A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors (NCT01456078) | Lund University Hospital | 2011-10-01 |
| CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells (NCT01373047) | Roger Williams Medical Center | 2011-06-01 |
| Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer (NCT01320683) | City of Hope Medical Center | 2011-03-01 |
| Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma (NCT01411579) | Stefano Colagrande | 2011-02-01 |
| Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure (NCT01348412) | Centre Georges Francois Leclerc | 2010-12-15 |
| Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients (NCT01322178) | Fudan University | 2010-12-01 |
| Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions (NCT01329458) | Societatea Romana de Ultrasonografie in Medicina si Biologie | 2010-12-01 |
| Individualized Stereotactic Body Radiotherapy of Liver Metastases (NCT01239381) | Massachusetts General Hospital | 2010-10-05 |
| Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer (NCT01285102) | Fox Chase Cancer Center | 2010-10-01 |
| rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors (NCT01071941) | Kenneth K. Tanabe, MD | 2010-10-01 |
| Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases (NCT01233544) | University of Aarhus | 2010-09-01 |
| Liver-PILP First-in-Man (NCT01250158) | Medical Device Works NV SA | 2010-09-01 |
| A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases (NCT01260415) | University Health Network, Toronto | 2010-08-01 |
| Stereotactic Body Radiation Therapy (SBRT) for Patients With Hepatic Metastases (NCT01162278) | University of Texas Southwestern Medical Center | 2010-07-01 |
| Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy (NCT01186263) | University of Magdeburg | 2010-07-01 |
| A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases (NCT01120288) | National Cancer Institute (NCI) | 2010-04-29 |
| Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease (NCT01387295) | Dorte Nielsen | 2010-04-01 |
| The Inflammatory Response to Stress and Angiogenesis in Liver Resection (NCT03131778) | University Hospital, Ghent | 2010-04-01 |
| Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer (NCT01387373) | Dorte Nielsen | 2010-04-01 |
| National Registry of Hepatic Metastases From Non-Colorectal Cancer" (NCT07180641) | Clinica Universidad de Navarra, Universidad de Navarra | 2010-01-01 |
| Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases (NCT01643070) | Asan Medical Center | 2010-01-01 |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery (NCT00835679) | National Cancer Institute (NCI) | 2009-12-01 |
| A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases (NCT00969410) | AVEO Pharmaceuticals, Inc. | 2009-08-01 |
| Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity (NCT01149304) | University of Magdeburg | 2009-06-01 |
| Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases (NCT00866944) | Amgen Research (Munich) GmbH | 2009-03-01 |
| Stereotactic Body Radiotherapy for Liver Tumors (NCT01347333) | Mercy Research | 2008-09-01 |
| FOLFIRI and Sunitinib in Metastatic Colorectal Cancer (NCT00806663) | Central European Society for Anticancer Drug Research | 2008-08-01 |
| Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy (NCT00852228) | Association pour la Recherche sur le Temps Biologique et la Chronothérapie | 2008-07-01 |
| FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma (NCT00735241) | Sirtex Medical | 2008-07-01 |
| Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis (NCT05462470) | Fudan University | 2008-01-01 |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms (NCT01640522) | University of Pittsburgh | 2008-01-01 |
| Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases (NCT00440310) | Light Sciences Oncology | 2007-02-01 |
| Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer (NCT00394992) | Dutch Colorectal Cancer Group | 2006-12-01 |
| FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer (NCT00724503) | Sirtex Medical | 2006-08-01 |
| Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases (NCT00265356) | Ontario Clinical Oncology Group (OCOG) | 2005-11-01 |
| Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery (NCT00645710) | City of Hope Medical Center | 2005-02-11 |
| Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases (NCT00156975) | Arbeitsgruppe Lebermetastasen und Tumoren | 2004-11-01 |
| Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) (NCT00153998) | Technische Universität Dresden | 2004-11-01 |
| Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases (NCT00242086) | University Health Network, Toronto | 2004-10-01 |
| Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF (NCT00661622) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2004-10-01 |
| Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver (NCT00290316) | Central Texas Veterans Health Care System | 2004-07-01 |
| Intensified Chemotherapy in CRC After Resection of Liver Metastases (NCT00208260) | Institut du Cancer de Montpellier - Val d'Aurelle | 2004-04-01 |
| Impact of PVE on Patient's Long-term Survival, Complications and Cancer Recurrence. (NCT03168230) | Université de Sherbrooke | 2004-02-27 |
| Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases. (NCT05273489) | Hospital Maciel | 2004-01-01 |
| Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients (NCT00228189) | Radboud University Medical Center | 2003-12-01 |
| Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases (NCT00501605) | AstraZeneca | 2003-02-01 |
| Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT00026234) | National Cancer Institute (NCI) | 2002-02-01 |
| Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma (NCT00168155) | Alberta Health services | 2002-01-01 |
| Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM (NCT06038552) | First Affiliated Hospital, Sun Yat-Sen University | 2002-01-01 |
| Prognosis of One-stage Hepatectomy for Bilobar Colorectal Metastases (NCT01683357) | University of Milan | 2001-09-01 |
| Alternative to Two-Stage Hepatectomy (NCT00587756) | University of Milan | 2001-09-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver (NCT00019760) | National Institutes of Health Clinical Center (CC) | 1999-04-01 |